Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Shearer

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Applied Health Economics and Health Policy|May 3, 2013
Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosisAnnie Hawton, James Shearer, Elizabeth Goodwin, et al.
Addictive Behaviors|September 4, 2004
Agonist-like, replacement pharmacotherapy for stimulant abuse and dependenceJohn Grabowski, James Shearer, John Merrill, et al.
Drug and Alcohol Review|August 22, 2002
Substitution therapy for amphetamine usersJames Shearer, John Sherman, Alex Wodak, et al.
International Journal of Environmental Research and Public Health|December 11, 2022
Effectiveness and Cost-Effectiveness of Mental Health Interventions Delivered by Frontline Health Care Workers in Emergency Health Services: A Systematic Review and Meta-AnalysisMin Peng, Tao Xiao, Ben Carter, et al.
Journal of Neurology|August 6, 2011
The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's diseaseJames Shearer, Colin Green, Carl E Counsell, et al.
Drugs & Aging|December 24, 2011
Health state values for use in the economic evaluation of treatments for Alzheimer's diseaseJames Shearer, Colin Green, Craig W Ritchie, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 16, 2011
Model-based economic evaluation in Alzheimer's disease: a review of the methods available to model Alzheimer's disease progressionColin Green, James Shearer, Craig W Ritchie, et al.
Applied Health Economics and Health Policy|June 21, 2011
The use of decision-analytic models in Parkinson's disease: a systematic review and critical appraisalJames Shearer, Colin Green, Carl E Counsell, et al.
Frontiers in Psychiatry|January 2, 2023
Evaluation of the effectiveness and cost-effectiveness of psychological first aid (PFA) system based training for frontline health workers in emergency health services in China a study protocol of a cluster randomized controlled trialMin Peng, Tao Xiao, Ben Carter, et al.
Addiction (Abingdon, England)|July 23, 2003
Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependenceJames Shearer, Alex Wodak, Ingrid van Beek, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Applied Health Economics and Health Policy|May 3, 2013
Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosisAnnie Hawton, James Shearer, Elizabeth Goodwin, et al.
Addictive Behaviors|September 4, 2004
Agonist-like, replacement pharmacotherapy for stimulant abuse and dependenceJohn Grabowski, James Shearer, John Merrill, et al.
Drug and Alcohol Review|August 22, 2002
Substitution therapy for amphetamine usersJames Shearer, John Sherman, Alex Wodak, et al.
International Journal of Environmental Research and Public Health|December 11, 2022
Effectiveness and Cost-Effectiveness of Mental Health Interventions Delivered by Frontline Health Care Workers in Emergency Health Services: A Systematic Review and Meta-AnalysisMin Peng, Tao Xiao, Ben Carter, et al.
Journal of Neurology|August 6, 2011
The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's diseaseJames Shearer, Colin Green, Carl E Counsell, et al.
Drugs & Aging|December 24, 2011
Health state values for use in the economic evaluation of treatments for Alzheimer's diseaseJames Shearer, Colin Green, Craig W Ritchie, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 16, 2011
Model-based economic evaluation in Alzheimer's disease: a review of the methods available to model Alzheimer's disease progressionColin Green, James Shearer, Craig W Ritchie, et al.
Applied Health Economics and Health Policy|June 21, 2011
The use of decision-analytic models in Parkinson's disease: a systematic review and critical appraisalJames Shearer, Colin Green, Carl E Counsell, et al.
Frontiers in Psychiatry|January 2, 2023
Evaluation of the effectiveness and cost-effectiveness of psychological first aid (PFA) system based training for frontline health workers in emergency health services in China a study protocol of a cluster randomized controlled trialMin Peng, Tao Xiao, Ben Carter, et al.
Addiction (Abingdon, England)|July 23, 2003
Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependenceJames Shearer, Alex Wodak, Ingrid van Beek, et al.
Pageof 8